# Bioequivalence Study of Generic Tretinoin 0.04% Microsphere Gel, 0.04% Retin-A Micro® and Placebo

> **NCT01243450** · PHASE3 · COMPLETED · sponsor: **Spear Pharmaceuticals** · enrollment: 958 (actual)

## Conditions studied

- Acne

## Interventions

- **DRUG:** Tretinoin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01243450
- **Lead sponsor:** Spear Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 958 (ACTUAL)
- **Last updated:** 2020-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01243450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01243450, "Bioequivalence Study of Generic Tretinoin 0.04% Microsphere Gel, 0.04% Retin-A Micro® and Placebo". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01243450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*